Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Avista Makes Annual Price Adjustment Requests in Washington

2018-08-17 globenewswire
SPOKANE, Wash., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Avista (NYSE: AVA) has made several annual rate adjustment filings with the Washington Utilities and Transportation Commission (UTC or Commission) that would, if approved, result in an overall decrease in electric and natural gas rates, effective Nov. 1, 2018.
H AVA HRNNF

0
Avista Corp. Board Declares Common Stock Dividend

2018-08-15 globenewswire
SPOKANE, Wash., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Avista Corp.’s (NYSE: AVA) board of directors has declared a quarterly dividend of $0.3725 per share on the company’s common stock. The common stock dividend is payable Sept. 14, 2018, to shareholders of record at the close of business on Aug. 31, 2018.
AVA

0
Hydro One given six months to trim executive pay

2018-08-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
H AVA HRNNF

0
PRESS DIGEST - Canada - August 13

2018-08-13 reuters
Aug 13 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
AVA

0
Growing Spokane, Washington, sheds its sleepy city image

2018-08-11 nzherald.co.nz
SPOKANE, Wash. (AP) — Ramsey and Amy Pruchnic lived in the Seattle area for five years before deciding they wanted to escape the Puget Sound rat race and move closer to family on the opposite side of the state.
AVA

0
AVA / Avista Corp. 8-K (Current Report)

2018-08-10 sec.gov
Document
AVA

0
Tesla Is Too Risky for These Traders - Bloomberg

2018-08-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
H TRBNW AVA HRNNF TRCO TRBAB

0
Avista Corporation 2018 Q2 - Results - Earnings Call Slides

2018-08-01 seekingalpha
The following slide deck was published by Avista Corporation in conjunction with their 2018 Q2 earnings call.
AVA

0
Avista Corp's (AVA) CEO Scott Morris on Q2 2018 Results - Earnings Call Transcript

2018-08-01 seekingalpha
Welcome to the Second Quarter 2018 Earnings Conference Call. My name is Adrianne, and I’ll be your operator for today’s call. At this time all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.
H AVA HRNNF

0
Avista Corp. Reports Financial Results for Second Quarter and Year-To-Date 2018, and Confirms 2018 Earnings Guidance

2018-08-01 globenewswire
SPOKANE, Wash., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today reported net income attributable to Avista Corp. shareholders of $25.6 million, or $0.39 per diluted share for the second quarter of 2018, compared to $21.8 million, or $0.34 per diluted share for the second quarter of 2017. For the six months ended June 30, 2018, net income attributable to Avista Corp. shareholders was $80.
H AVA HRNNF

0
AVA / Avista Corp. 10-Q (Quarterly Report)

2018-08-01 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
AVA

0
AVA / Avista Corp. 8-K (Current Report)

2018-08-01 sec.gov
Document
AVA

40
Continue Snoozing On MDU Resources

2018-07-31 seekingalpha
There are two potential "growth kickers" that could translate into wins for the company and its shareholders.
SOJA SO GVA LNT STRL CQP UPS LNG NWE ATO BKH EME MYRG VVC VMC AVA PWR BKHU WACC MLM

1
Avista Requests Natural Gas Rate Decrease for Oregon Customers in Annual Cost Adjustment Filings

2018-07-27 globenewswire - 1
SPOKANE, Wash., July 27, 2018 (GLOBE NEWSWIRE) -- Avista’s (NYSE: AVA) customers in Oregon would see a decrease in their natural gas rates effective Nov. 1, 2018 if the Public Utility Commission of Oregon (OPUC or Commission) approves the company’s annual rate adjustment filings. These filings have no impact on the company’s earnings and are not related to the proposed acquisition of Avista by Hydro One.
H AVA HRNNF

0
Idaho Public Utilities Commission postpones Avista and Hydro One merger technical hearing

2018-07-19 globenewswire
TORONTO and SPOKANE, Wash., July 19, 2018 (GLOBE NEWSWIRE) -- Hydro One Limited (“Hydro One”) (TSX:H) and Avista Corporation (“Avista”) (NYSE:AVA) previously announced that the Idaho Public Utilities Commission (the “Commission”) had set a technical hearing on July 23, 2018. Today, the Commission decided to postpone this hearing. A new date has not yet been scheduled.
H AVA HRNNF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 05379B107